Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03244384
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-10-23T00:04:32.738011+00:00
Published At
2026-10-22T00:00:00+00:00
Record Updated At
2026-10-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Localized Renal Pelvis and Ureter Urothelial Carcinoma", "Locally Advanced Bladder Urothelial Carcinoma", "Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma", "Locally Advanced Ureter Urothelial Carcinoma", "Locally Advanced Urothelial Carcinoma", "Stage II Bladder Urothelial Carcinoma AJCC v6 and v7", "Stage II Renal Pelvis and Ureter Cancer AJCC v7", "Stage II Ureter Cancer AJCC v7", "Stage III Bladder Urothelial Carcinoma AJCC v6 and v7", "Stage III Renal Pelvis and Ureter Cancer AJCC v7", "Stage III Ureter Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-10-22"
protocolSection.identificationModule.nctId
"NCT03244384"
protocolSection.identificationModule.officialTitle
"Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Localized Renal Pelvis and Ureter Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Bladder Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Ureter Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage II Renal Pelvis and Ureter Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage II Ureter Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Renal Pelvis and Ureter Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Ureter Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.